Is Moderna Stock Really Headed to $112?
Published
Wall Street analysts are cranking up their price targets on the biotech in response to early clinical trial results for its coronavirus vaccine candidate.
Full ArticlePublished
Wall Street analysts are cranking up their price targets on the biotech in response to early clinical trial results for its coronavirus vaccine candidate.
Full Article